How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | PODDINSULET CORP | PENPenumbra Inc | BAXBAXTER INTERNATIONAL INC | GMEDGLOBUS MEDICAL INC | Median of the restexcluding PODD |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $148.12▲ 6.22 (4.38%) | $324.96▲ 1.40 (0.43%) | $25.65▲ 0.95 (3.85%) | $81.66▲ 2.98 (3.79%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 8.7/10 | 10.0/10 | 5.0/10 | 10.0/10 | 10.0/10 |
| Market value | $10.43B | $12.75B | $13.12B | $11.23B | |
| Revenue | $2.71B | $1.40B | $11.24B | $2.94B | |
| Profit | $247.1M | $177.7M | -$957.0M | $537.9M | |
| Revenue growthChange in sales versus the prior year. | 30.7% | 17.5% | 5.7% | 16.7% | 16.7% |
| Gross marginShare of sales left after the direct cost of producing them. | 71.6% | 67.1% | 30.1% | 67.4% | 67.1% |
| Operating marginShare of sales left after running the business, before interest and tax. | 17.5% | 13.5% | -2.7% | 16.3% | 13.5% |
| Profit marginProfit kept from each dollar of sales. | 9.1% | 12.7% | -8.5% | 18.3% | 12.7% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 13.9% | 12.5% | 3.0% | 20.0% | 12.5% |
| Return on equityProfit against the owners' stake in the company. | 16.3% | 12.4% | -15.6% | 11.8% | 11.8% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 19.7% | 13.2% | -1.8% | 10.5% | 10.5% |
| P/E ratioPrice paid per dollar of annual profit. | 42.19x | 71.74x | — | 20.88x | 46.31x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 18.89x | — | 30.60x | — | 30.60x |
| Price to book | 6.88x | 8.93x | 2.14x | 2.46x | 2.46x |
| Debt to equityTotal liabilities compared with owners' stake. | 1.11x | 0.28x | 2.28x | 0.16x | 0.28x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 7/9 | 7/8 | 6/9 | 8/8 | 7.0 |
| Bankruptcy riskAltman Z-Score zone. | safe | safe | grey | safe |
How PODD compares with the others
- PODD's operating margin of 17.5% is higher than the median of the other companies selected (13.5%).
- Its revenue grew faster than the median of the other companies selected: 30.7% against 16.7%.
- It trades at a P/E in line with the median of the other companies selected (42.2x against 46.3x).
- Its liabilities are higher relative to equity than the median of the other companies selected: 1.1x against 0.3x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.